Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: A comparative effectiveness analysis from the DEcIDE-ESRD study

Nephrology Dialysis Transplantation

Volumn 30, Issue 4, 2015, Pages 667-675

  Tangri, Navdeep ^a   Miskulin, Dana C ^b,n   Zhou, Jing ^c,d,i   Bandeen Roche, Karen ^e,i   Michels, Wieneke M ^c,d,f,i,p   Ephraim, Patti L ^d,e,i   McDermott, Aidan ^e,i   Crews, Deidra C ^c,d,i   Scialla, Julia J ^g,o   Sozio, Stephen M ^c,d,i   Shafi, Tariq ^c,d,i   Jaar, Bernard G ^c,d,h,i   Meyer, Klemens ^b,n   Boulware, L Ebony ^a,c,d,i   Cook, Courtney ⁱ   Coresh, Josef ⁱ   Kim, Jeonyong ⁱ   Liu, Yang ⁱ   Luly, Jason ⁱ   Scheel, Paul ⁱ   Wu, Albert ⁱ   Powe, Neil ^j   Collins, Allan ^k   Foley, Robert ^k   Gilbertson, David ^k   Guo, Haifeng ^k   Heubner, Brooke ^k   Herzog, Charles ^k   Liu, Jiannong ^k   St Peter, Wendy ^k   Nally, Joseph ^l   Arrigain, Susana ^l   Jolly, Stacey ^l   Konig, Vicky ^l   Liu, Xiaobo ^l   Navaneethan, Sankar ^l   Schold, Jesse ^l   Zager, Philip ^m   more..

^a UNIVERSITY OF MANITOBA   (Canada)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h NEPHROLOGY CENTER OF MARYLAND   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^l LERNER RESEARCH INSTITUTE   (United States)

^m UNIVERSITY OF NEW MEXICO   (United States)

ⁿ TUFTS UNIVERSITY   (United States)

^o UNIVERSITY OF MIAMI   (United States)

^p ACADEMIC MEDICAL CENTER   (Netherlands)

more..

Author keywords

anemia; hemodialysis; hospitalizations; intravenous iron

Indexed keywords

IRON; IRON DERIVATIVE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; ELECTRONIC MEDICAL RECORD; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMPARATIVE STUDY; COMPLICATION; FACTUAL DATABASE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ADMINISTRATION, INTRAVENOUS; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DATABASES, FACTUAL; FEMALE; HOSPITALIZATION; HUMANS; IRON COMPOUNDS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS;

EID: 84926677066     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu349     Document Type: Article

References (26)

1. Coladonato JA, Frankenfield DL, Reddan DN et al. Trends in anemia management among US hemodialysis patients. J Am Soc Nephrol 2002; 13: 1288-1295
2. Pisoni RL, Bragg-Gresham JL, Young EW et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 94-111
3. Miskulin DC, Zhou J, Tangri N et al. Trends in anemia management in US hemodialysis patients 2004-2010. BMC Nephrol 2013; 14: 264
4. Freburger JK, Ng LJ, Bradbury BD et al. Changing patterns of anemia management in US hemodialysis patients. Am J Med 2012; 125: 906-914 e909
5. Fuller DS, Pisoni RL, Bieber BA et al. The DOPPS practice monitor for US dialysis care: trends through December 2011. Am J Kidney Dis 2013; 61: 342-346
6. Drüeke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084
7. Fishbane S, Hazzan A. Meeting the 2012 QIP (Quality Incentive Program) clinical measures: strategies for dialysis centers. Am J Kidney Dis 2012; 60 (Suppl. 1): S5-13; quiz S14-S17
8. Pfeffer MA, Burdmann EA, Chen CY et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361: 2019-2032
9. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
10. Canavese C, Bergamo D, Ciccone G et al. Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients. Kidney Int 2004; 65: 1091-1098
11. Rostoker G, Griuncelli M, Loridon C et al. Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study. Am J Med 2012; 125: 991-999 e991
12. Ghoti H, Rachmilewitz EA, Simon-Lopez R et al. Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. Eur J Haematol 2012; 89: 87-93
13. Brewster UC, Perazella MA. Intravenous iron and the risk of infection in end-stage renal disease patients. Semin Dial 2004; 17: 57-60
14. Brewster UC, Coca SG, Reilly RF et al. Effect of intravenous iron on haemodialysis catheter microbial colonization and blood-borne infection. Nephrology (Carlton) 2005; 10: 124-128
15. Kuo KL, Hung SC, Wei YH et al. Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol 2008; 19: 1817-1826
16. Toblli JE, Cao G, Olivieri L et al. Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds. Nephrol Dial Transplant 2010; 25: 3631-3640
17. Brookhart MA, Freburger JK, Ellis AR et al. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol 2013; 24: 1151-1158
18. Boulware EL, Tangri N, Ephraim PL et al. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol 2012; 13: 167
19. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11: 561-570
20. Andersen PA, Gill R. Cox's regression model for counting processes: a large sample study. Ann Statist 1982; 10: 1100-1120
21. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130
22. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ 2013; 347: f4822
23. Feldman HI, Santanna J, Guo W et al. Iron administration and clinical outcomes in hemodialysis patients. J Am Soc Nephrol 2002; 13: 734-744
24. Feldman HI, Joffe M, Robinson B et al. Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol 2004; 15: 1623-1632
25. Kalantar-Zadeh K, Regidor DL, McAllister CJ et al. Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16: 3070-3080
26. Brennan JM, Peterson ED, Messenger JC et al. Linking the National Cardiovascular Data Registry CathPCI Registry with Medicare claims data: validation of a longitudinal cohort of elderly patients undergoing cardiac catheterization. Circ Cardiovasc Qual Outcomes 2012; 5: 134-140